HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

Monica Vaccari(Tulane University), Genoveffa Franchini(National Institutes of Health), Hung V. Trinh(Henry M. Jackson Foundation), Dai Fujikawa(National Cancer Institute), Richard A. Koup(Aaron Diamond AIDS Research Center), David Venzon(National Institutes of Health), Georgia D. Tomaras(National Institutes of Health), Shari N. Gordon(National Cancer Institute), Veronica Galli(National Cancer Institute), Slim Fourati(Emory University), Rafick‐Pierre Sékaly(University Hospitals of Cleveland), Marcus P. Wong(University of California, Irvine), Isabela Silva de Castro(National Cancer Institute), Kathryn E. Foulds, Johannes S. Gach(University of California, Irvine), Namal P. M. Liyanage(National Cancer Institute), Xiaoying Shen(University of California, Los Angeles), Margherita Rosati(National Cancer Institute), Brandon F. Keele(Frederick National Laboratory for Cancer Research), Massimiliano Bissa(National Cancer Institute), Melvin N. Doster(National Cancer Institute), George N. Pavlakis(National Institutes of Health), Giacomo Gorini(National Cancer Institute), Barbara K. Felber(Frederick National Laboratory for Cancer Research), Dallas R. Brown(National Cancer Institute), Karissa J. Muñoz(University of California, Irvine), Donald N. Forthal(NorthShore University HealthSystem), Katherine McKinnon(National Institutes of Health), Maria Omsland(University of Bergen), Mario Roederer(National Institutes of Health), Luca Schifanella(University of Minnesota Medical Center), Mangala Rao(Walter Reed Army Institute of Research), David C. Montefiori(Duke University)
Nature Medicine
May 18, 2018
Cited by 77


Related Papers